CGON
Price
$42.38
Change
-$0.17 (-0.40%)
Updated
Nov 19, 01:33 PM (EDT)
Capitalization
3.43B
Intraday BUY SELL Signals
KYMR
Price
$64.86
Change
+$0.55 (+0.86%)
Updated
Nov 19, 01:48 PM (EDT)
Capitalization
4.63B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs KYMR

Header iconCGON vs KYMR Comparison
Open Charts CGON vs KYMRBanner chart's image
CG Oncology
Price$42.38
Change-$0.17 (-0.40%)
Volume$625
Capitalization3.43B
Kymera Therapeutics
Price$64.86
Change+$0.55 (+0.86%)
Volume$125
Capitalization4.63B
CGON vs KYMR Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. KYMR commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (CGON: $42.55 vs. KYMR: $64.38)
Brand notoriety: CGON and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 105% vs. KYMR: 48%
Market capitalization -- CGON: $3.43B vs. KYMR: $4.63B
CGON [@Biotechnology] is valued at $3.43B. KYMR’s [@Biotechnology] market capitalization is $4.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGON and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 4 bullish, 5 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а +9.55% price change this week, while KYMR (@Biotechnology) price change was +1.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.63B) has a higher market cap than CGON($3.43B). KYMR YTD gains are higher at: 60.017 vs. CGON (48.361). CGON has higher annual earnings (EBITDA): -157.09M vs. KYMR (-267.03M). KYMR (665M) and CGON (661M) have equal amount of cash in the bank . CGON has less debt than KYMR: CGON (994K) vs KYMR (85.7M). KYMR has higher revenues than CGON: KYMR (44.7M) vs CGON (551K).
CGONKYMRCGON / KYMR
Capitalization3.43B4.63B74%
EBITDA-157.09M-267.03M59%
Gain YTD48.36160.01781%
P/E RatioN/AN/A-
Revenue551K44.7M1%
Total Cash661M665M99%
Total Debt994K85.7M1%
TECHNICAL ANALYSIS
Technical Analysis
CGONKYMR
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
80%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TISVX17.57N/A
N/A
Transamerica International Sm Cp Val I
AGCLX19.35N/A
N/A
American Century Global Small Cap A
MNVRX28.65-0.07
-0.24%
Madison Large Cap R6
GBLEX41.32-0.21
-0.51%
American Funds Global Balanced F1
JORCX19.53-0.19
-0.96%
Janus Henderson Global Select C

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+3.15%
SYRE - CGON
58%
Loosely correlated
-1.07%
NUVL - CGON
57%
Loosely correlated
-3.48%
IDYA - CGON
57%
Loosely correlated
+1.08%
ACLX - CGON
56%
Loosely correlated
-0.49%
KYMR - CGON
54%
Loosely correlated
+0.43%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.43%
NRIX - KYMR
64%
Loosely correlated
-1.02%
VERA - KYMR
61%
Loosely correlated
-2.00%
IDYA - KYMR
54%
Loosely correlated
+1.08%
RGNX - KYMR
54%
Loosely correlated
+0.94%
NUVL - KYMR
54%
Loosely correlated
-3.48%
More